๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Increased 1,25-dihydroxyvitamin D in patients with generalized scleroderma andnoaberrant calcifications

โœ Scribed by J. Serup; H. K. Hagdrup

Book ID
104764588
Publisher
Springer-Verlag
Year
1984
Tongue
English
Weight
177 KB
Volume
276
Category
Article
ISSN
0340-3696

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hexafluoro-1,25-dihydroxyvitamin D3 has
Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3
โœ T.C. Chen; M.F. Holick ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 409 KB

## Background: Although topical 1,25-dihydroxyvitamin d3 (calcitriol, 1, 25(oh)2d3) and its analogues, calcipotriol and tacalcitol, are effective for patients with psoriasis, some patients show little or no response. there is a need to develop more potent analogues of 1, 25(oh)2d3. hexafluoro-1,25(

Increased PKC activity in cultured human
Increased PKC activity in cultured human keratinocytes and fibroblasts after treatment with 1ฮฑ,25-dihydroxyvitamin D3
โœ Nancy M. Hanafin; Kelly Scott Persons; Michael F. Holick ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 751 KB

la,25-Dihydroxyvitarnin D3 (10-l2 M to M) caused a dose dependent increase in PKC activity in the solubilized membrane fractions of cultured human keratinocytes and in the cytosolic fractions of cultured human fibroblasts. Maximum activity was induced by 1 a,25-dihydroxyvitamin D3 at 24 h. Sphingosi